These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 27722159)

  • 1. NASH Cirrhosis - the New Burden in Liver Transplantation: How Should It Be Managed?
    Canbay A; Sowa JP; Syn WK; Treckmann J
    Visc Med; 2016 Aug; 32(4):234-238. PubMed ID: 27722159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.
    Estes C; Anstee QM; Arias-Loste MT; Bantel H; Bellentani S; Caballeria J; Colombo M; Craxi A; Crespo J; Day CP; Eguchi Y; Geier A; Kondili LA; Kroy DC; Lazarus JV; Loomba R; Manns MP; Marchesini G; Nakajima A; Negro F; Petta S; Ratziu V; Romero-Gomez M; Sanyal A; Schattenberg JM; Tacke F; Tanaka J; Trautwein C; Wei L; Zeuzem S; Razavi H
    J Hepatol; 2018 Oct; 69(4):896-904. PubMed ID: 29886156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatic steatosis : Differential diagnostics and current aspects].
    Canbay A; Gerken G; Bechmann LP
    Internist (Berl); 2016 Sep; 57(9):879-92. PubMed ID: 27510334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis.
    Villeret F; Dharancy S; Erard D; Abergel A; Barbier L; Besch C; Boillot O; Boudjema K; Coilly A; Conti F; Corpechot C; Duvoux C; Faitot F; Faure S; Francoz C; Giostra E; Gugenheim J; Hardwigsen J; Hilleret MN; Hiriart JB; Houssel-Debry P; Kamar N; Lassailly G; Latournerie M; Pageaux GP; Samuel D; Vanlemmens C; Saliba F; Dumortier J
    JHEP Rep; 2023 Mar; 5(3):100668. PubMed ID: 36852108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation and non-alcoholic fatty liver disease.
    Zezos P; Renner EL
    World J Gastroenterol; 2014 Nov; 20(42):15532-8. PubMed ID: 25400437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAFLD and liver transplantation: Disease burden, current management and future challenges.
    Burra P; Becchetti C; Germani G
    JHEP Rep; 2020 Dec; 2(6):100192. PubMed ID: 33163950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.
    Athyros VG; Alexandrides TK; Bilianou H; Cholongitas E; Doumas M; Ganotakis ES; Goudevenos J; Elisaf MS; Germanidis G; Giouleme O; Karagiannis A; Karvounis C; Katsiki N; Kotsis V; Kountouras J; Liberopoulos E; Pitsavos C; Polyzos S; Rallidis LS; Richter D; Tsapas AG; Tselepis AD; Tsioufis K; Tziomalos K; Tzotzas T; Vasiliadis TG; Vlachopoulos C; Mikhailidis DP; Mantzoros C
    Metabolism; 2017 Jun; 71():17-32. PubMed ID: 28521870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease.
    Mishra A; Younossi ZM
    J Clin Exp Hepatol; 2012 Jun; 2(2):135-44. PubMed ID: 25755422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.
    Dhamija E; Paul SB; Kedia S
    Indian J Med Res; 2019 Jan; 149(1):9-17. PubMed ID: 31115369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnosis and treatment of non-alcoholic fatty liver disease.
    Altinbas A; Sowa JP; Hasenberg T; Canbay A
    Minerva Gastroenterol Dietol; 2015 Sep; 61(3):159-69. PubMed ID: 26080905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
    Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M
    Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.
    Perumpail RB; Wong RJ; Ahmed A; Harrison SA
    Dig Dis Sci; 2015 Oct; 60(10):3142-8. PubMed ID: 26250831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence of fatty liver disease following liver transplantation for NAFLD-related cirrhosis: Current status and challenges.
    Dooghaie Moghadam A; Eslami P; Razavi-Khorasani N; Moazzami B; Zahedi-Tajrishi F; Farokhi E; Makhdoomi Sharabiani K; Mansour-Ghanaei A; Mehrvar A; Aghajanpoor Pasha M; Saeedi S; Iravani S
    Caspian J Intern Med; 2020; 11(4):346-354. PubMed ID: 33680375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Natural Course of Non-Alcoholic Fatty Liver Disease.
    Calzadilla Bertot L; Adams LA
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study Design.
    Xu ZJ; Shi JP; Yu DR; Zhu LJ; Jia JD; Fan JG
    Adv Ther; 2016 Nov; 33(11):2069-2081. PubMed ID: 27743352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
    Vernon G; Baranova A; Younossi ZM
    Aliment Pharmacol Ther; 2011 Aug; 34(3):274-85. PubMed ID: 21623852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma.
    Said A; Ghufran A
    World J Clin Oncol; 2017 Dec; 8(6):429-436. PubMed ID: 29291167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation for non-alcoholic fatty liver disease.
    Germani G; Becchetti C
    Minerva Gastroenterol Dietol; 2018 Jun; 64(2):138-146. PubMed ID: 29249127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease: A growing public health problem in Turkey.
    Kaya E; Yılmaz Y
    Turk J Gastroenterol; 2019 Oct; 30(10):865-871. PubMed ID: 31258135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.